CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

24 hedge funds and large institutions have $7.48M invested in COSCIENS Biopharma Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+7
Holders Change %
+41.18%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
13
Increased
6
Reduced
2
Closed
5
Calls
$90K
Puts
$1K
Net Calls
+$89K
Net Calls Change
+$101K

Top Buyers

1
JGC
1
J. Goldman & Co
New York
$2.93M
2
AFM
2
Anson Funds Management
Texas
$987K
3
Morgan Stanley
3
Morgan Stanley
New York
$2.08M
4
BCM
4
Bridgeway Capital Management
Texas
$326K
5
BFM
5
Boothbay Fund Management
New York
$135K

Top Sellers

1
VF
1
Virtu Financial
New York
$0
2
UBS Group
2
UBS Group
Switzerland
$3K
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
ARTA
4
A.R.T. Advisors
New York
$0
5
BA
5
Ballew Advisors
Mississippi
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BA
26
Ballew Advisors
Mississippi
– -$4K -30 Closed
Toronto Dominion Bank
27
Toronto Dominion Bank
Ontario, Canada
– -$1K -4 Closed
1
2